Antihypertensive AgentsBlood PressureHypertensionBlood Pressure DeterminationBlood Pressure Monitoring, AmbulatoryPressureHydrochlorothiazideAngiotensin-Converting Enzyme InhibitorsDiureticsAtenololAmlodipineCalcium Channel BlockersHydralazineMethyldopaRats, Inbred SHRHeart RateSodium Chloride Symporter InhibitorsAdrenergic beta-AntagonistsMinoxidilBendroflumethiazideCaptoprilAngiotensin II Type 1 Receptor BlockersDoxazosinTetrazolesSystoleLisinoprilReninEnalaprilHypertension, RenalAngiotensin Receptor AntagonistsClonidineDihydropyridinesNordefrinIndapamideRenin-Angiotensin SystemGlutamyl AminopeptidaseHemodynamicsLabetalolDrug Therapy, CombinationRats, Inbred WKYTreatment OutcomePerindoprilDouble-Blind MethodGuanfacineLosartanTime FactorsNifedipineKidneyHydrostatic PressurePropanolaminesBenzimidazolesCardiovascular DiseasesRisk FactorsBlood Pressure MonitorsImidazoline ReceptorsDose-Response Relationship, DrugPrazosinHypertension, RenovascularDiltiazemCardiovascular SystemProspective StudiesFollow-Up StudiesChlorthalidoneDesoxycorticosteroneSympathetic Nervous SystemPatient ComplianceAdrenergic alpha-AntagonistsPropranololDiastoleBiphenyl CompoundsArteriesPulseImidazolesKidney Failure, ChronicFumaratesClinical Trials as TopicAortaHypotensionMedication AdherenceDiabetes Mellitus, Type 2Vascular ResistanceValineVasodilator AgentsProteinuriaHypertrophy, Left VentricularDiabetic NephropathiesDrug CombinationsArterial PressureIntracranial PressureCircadian RhythmKidney DiseasesPhenylacetatesIntraocular PressureDiabetes ComplicationsBenzopyransAngiotensin IIAdministration, OralRandomized Controlled Trials as TopicTransducers, PressureRisk Assessment